Scleroderma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Alerts
• Clinical Trials

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
Conditions:   Systemic Sclerosis;   Scleroderma Interventions:   Biological: Anifrolumab (blinded);   Drug: Placebo (blinded);   Biological: Anifrolumab (unblinded, open label) Sponsor:   AstraZeneca Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 29, 2023 Category: Research Source Type: clinical trials

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Condition:   Interstitial Lung Disease Interventions:   Drug: efzofitimod 450 mg;   Drug: efzofitimod 270 mg;   Drug: Placebo Sponsor:   aTyr Pharma, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 7, 2023 Category: Research Source Type: clinical trials